Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer von González-Martín, Antonio, Pothuri, Bhavana, Vergote, Ignace, DePont Christensen, René, Graybill, Whitney, Mirza, Mansoor R, McCormick, Colleen, Lorusso, Domenica, Hoskins, Paul, Freyer, Gilles, Baumann, Klaus, Jardon, Kris, Redondo, Andrés, Moore, Richard G, Vulsteke, Christof, O’Cearbhaill, Roisin E, Lund, Bente, Backes, Floor, Barretina-Ginesta, Pilar, Haggerty, Ashley F, Rubio-Pérez, Maria J, Shahin, Mark S, Mangili, Giorgia, Bradley, William H, Bruchim, Ilan, Sun, Kaiming, Malinowska, Izabela A, Li, Yong, Gupta, Divya, Monk, Bradley J

Volltext

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer von Mirza, Mansoor R., Chase, Dana M., Slomovitz, Brian M., dePont Christensen, René, Novák, Zoltán, Black, Destin, Gilbert, Lucy, Sharma, Sudarshan, Valabrega, Giorgio, Landrum, Lisa M., Hanker, Lars C., Stuckey, Ashley, Boere, Ingrid, Gold, Michael A., Auranen, Annika, Pothuri, Bhavana, Cibula, David, McCourt, Carolyn, Raspagliesi, Francesco, Shahin, Mark S., Gill, Sarah E., Monk, Bradley J., Buscema, Joseph, Herzog, Thomas J., Copeland, Larry J., Tian, Min, He, Zangdong, Stevens, Shadi, Zografos, Eleftherios, Coleman, Robert L., Powell, Matthew A.

Volltext

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer von Eskander, Ramez N., Sill, Michael W., Beffa, Lindsey, Moore, Richard G., Hope, Joanie M., Musa, Fernanda B., Mannel, Robert, Shahin, Mark S., Cantuaria, Guilherme H., Girda, Eugenia, Mathews, Cara, Kavecansky, Juraj, Leath, Charles A., Gien, Lilian T., Hinchcliff, Emily M., Lele, Shashikant B., Landrum, Lisa M., Backes, Floor, O’Cearbhaill, Roisin E., Al Baghdadi, Tareq, Hill, Emily K., Thaker, Premal H., John, Veena S., Welch, Stephen, Fader, Amanda N., Powell, Matthew A., Aghajanian, Carol

Volltext

A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254) von Chan, John K., Brady, William, Monk, Bradley J., Brown, Jubilee, Shahin, Mark S., Rose, Peter G., Kim, Jae-Hoon, Secord, Angeles Alvarez, Walker, Joan L., Gershenson, David M.

Volltext

Changes to outpatient evaluation and management coding: 2021 will be a better year von Holtz, David O., Shahin, Mark S.

Volltext

Surgery in Advanced Ovary Cancer: Primary versus Interval Cytoreduction von Cummings, Mackenzie, Nicolais, Olivia, Shahin, Mark

Volltext

Population pharmacokinetics and exposure–response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY von Kuchimanchi, Mita, Jørgensen, Trine Lembrecht, Hanze, Eva, André, Thierry, Jain, Angela, Berton, Dominique, Alskär, Oskar, Zub, Oleksandr, Oaknin, Ana, Shahin, Mark S., Koliadi, Anthoula, Pothuri, Bhavana, Krivak, Tom, Pishchyk, Mikalai, Segev, Yakir, Backes, Floor J., Gennigens, Christine, Bouberhan, Sara, Zajic, Stefan, Melhem, Murad, Buscema, Joseph

Volltext

Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study von Swisher, Elizabeth M., Aghajanian, Carol, O'Malley, David M., Fleming, Gini F., Kaufmann, Scott H., Levine, Douglas A., Birrer, Michael J., Moore, Kathleen N., Spirtos, Nick M., Shahin, Mark S., Reid, Thomas J., Friedlander, Michael, Steffensen, Karina Dahl, Okamoto, Aikou, Sehgal, Vasudha, Ansell, Peter J., Dinh, Minh H., Bookman, Michael A., Coleman, Robert L.

Volltext

An SGO commentary: U.S. News and World Report gynecologic oncology procedural ratings–Do they reflect high-quality care? von Fader, Amanda N., Ko, Emily M., Pollock, Benjamin D., Blank, Stephanie V., Cohn, David E., Huh, Warner, Shahin, Mark S., Dowdy, Sean C.

Volltext

A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231D von Hyman, David M, MD, Sill, Michael W, PhD, Lankes, Heather A, PhD, Piekarz, Richard, MD, PhD, Shahin, Mark S, MD, Ridgway, Mildred R, MD, Backes, Floor, MD, Tenney, Meaghen E, MD, Mathews, Cara A., MD, Hoffman, James S, MD, Aghajanian, Carol, MD, PhD, Hensley, Martee L, MD

Volltext

Disparities Among Cervical Cancer Patients Receiving Brachytherapy von Bruce, Shaina F., Joshi, Tanvi V., Chervoneva, Inna, Yi, Misung, Chatterjee-Paer, Sudeshna, Burton, Elizabeth R., Edelson, Mitchell I., Sorosky, Joel I., Shahin, Mark S.

Volltext

Juvenile granulosa cell tumor in an adult woman during pregnancy: A case report and review of the literature von Cummings, Mackenzie, Edmonds, Pamela, Shahin, Mark S., Sorosky, Joel I.

Volltext

Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study von O'Cearbhaill, Roisin E., Pérez-Fidalgo, Jose-Alejandro, Monk, Bradley J., Tusquets, Ignacio, McCormick, Colleen, Fuentes, Jose, Moore, Richard G., Vulsteke, Christof, Shahin, Mark S., Forget, Frédéric, Bradley, William H., Hietanen, Sakari, O'Malley, David M., Dørum, Anne, Slomovitz, Brian M., Baumann, Klaus, Selle, Frédéric, Calvert, Paula M., Artioli, Grazia, Levy, Tally, Kumar, Aalok, Malinowska, Izabela A., Li, Yong, Gupta, Divya, González-Martín, Antonio

Volltext

Since surgery isn't getting any easier, why is reimbursement going down? An update from the SGO taskforce on coding and reimbursement von Uppal, Shitanshu, Shahin, Mark S, Rathbun, Jill A, Goff, Barbara A

Volltext

Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-c... von Powell, Matthew A., Cibula, David, O'Malley, David M., Boere, Ingrid, Shahin, Mark S., Savarese, Antonella, Chase, Dana M., Gilbert, Lucy, Black, Destin, Herrstedt, Jørn, Sharma, Sudarshan, Kommoss, Stefan, Gold, Michael A., Thijs, Anna M., Ring, Kari, Bolling, Magnus Frödin, Buscema, Joseph, Gill, Sarah E., Nowicki, Paul, Nevadunsky, Nicole, Callahan, Michael, Willmott, Lyndsay, McCourt, Carolyn, Billingsley, Caroline, Ghamande, Sharad A., He, Zangdong, Balas, Morad Marco, Stevens, Shadi, Fleming, Evelyn, Mirza, Mansoor Raza

Volltext

Vaginal lacerations during laparoscopic hysterectomy for endometrial cancer and local recurrence risk von Nicolais, Olivia, Cummings, Mackenzie, Buchanan, Tommy R, Moukarzel, Lea, Cardillo, Nicholas, Burton, Elizabeth, Edelson, Mitchell I., Shahin, Mark S.

Volltext

Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study von Schilder, Russell J, Brady, William E, Lankes, Heather A, Fiorica, James V, Shahin, Mark S, Zhou, Xun C, Mannel, Robert S, Pathak, Harsh B, Hu, Wei, Alpaugh, R. Katherine, Sood, Anil K, Godwin, Andrew K

Volltext

A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal... von Coleman, Robert L, Brady, William E, McMeekin, D. Scott, Rose, Peter G, Soper, John T, Lentz, Samuel S, Hoffman, James S, Shahin, Mark S

Volltext

SGO Health Policy and Socioeconomic Committee: Current and Future Efforts of the Coding and Reimbursement Taskforce and the Policy, Quality and Outcomes Taskforce von Goff, Barbara A., MD, Shahin, Mark S., MD, Powell, Matthew A., MD, Dowdy, Sean C., MD

Volltext

Implementation of an abdominal closure bundle to reduce surgical site infection in patients on a gynecologic oncology service undergoing exploratory laparotomy von Bruce, Shaina F., Carr, Danielle N., Burton, Elizabeth R., Sorosky, Joel I., Shahin, Mark S., Naglak, Mary C., Edelson, Mitchell I.

Volltext